Which means that cbd in general has fda support. Now that those wheels are turning, and thc rescheduling hearings are taking place, it won't be long before fda approvals of cbd products happen.
And when cannabis as a whole (thc containing products) gets federally rescheduled and states legalize recreational use of marijuana, (multiple states already have done that, more coming also) these snake oil companies (HTC for example) will simply fade away.
Ubqu's saving grace would be to become the first cbd product to recieve fda approval. But that would require major testing and proven results which ubqu can't and won't do.
Believe what you want, I trust the charts and company track record over those trying to be positive in the face of a continuously falling pps.
Said it before, and I'll say it again, ubqu is lose money.
It's bottom will be .005 in December.
News 
Market Data 
Discover 
AI
